Company profilePharmaceutical#319 of 1,318 in Pakistan✓ No DRAP alerts

HARMANN PHARMACEUTICAL LABORATORIES (PVT) LTD.

Pharmaceutical company · 55 brands · 71 molecules

Ranked #212 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

55 registered products 33 pharmaceutical brands 71 distinct molecules 0 DRAP alerts

Company overview

55
registered products
33
pharmaceutical brands
71
distinct molecules
12
therapeutic classes
0
DRAP alerts

HARMANN PHARMACEUTICAL LABORATORIES (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 55 product registrations across 71 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antifungal For Dermatological. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Pyridoxine5 brands
Thiamine5 brands
Riboflavin4 brands
Gentamicin3 brands
Nutritional Supplement / Multivitamin2 brands
Eye2 brands
Hyoscine2 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 2Antifungal For Dermatological · 2Drugs For Constipation · 1Mydriatics And Cycloplegics · 1Antispasmodic & Anticholinergic · 1Ace Inhibitor · 1Anthelmintic · 1Vitamin B1, & Combinations Of B1, B6, B12 · 1Antihistamines For Systemic Use · 1Antianemic, Iron & All Combination · 1Other Beta-Lactam, Cephalosporins & Penems · 1Vitamin B12 Plain · 1

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for HARMANN

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.